276 related articles for article (PubMed ID: 8814165)
1. Disseminated ependymomas of the central nervous system.
Rezai AR; Woo HH; Lee M; Cohen H; Zagzag D; Epstein FJ
J Neurosurg; 1996 Oct; 85(4):618-24. PubMed ID: 8814165
[TBL] [Abstract][Full Text] [Related]
2. Spinal ependymomas. Part 2: Ependymomas of the filum terminale.
Klekamp J
Neurosurg Focus; 2015 Aug; 39(2):E7. PubMed ID: 26235024
[TBL] [Abstract][Full Text] [Related]
3. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
Lukashova-v Zangen I; Kneitz S; Monoranu CM; Rutkowski S; Hinkes B; Vince GH; Huang B; Roggendorf W
Acta Neuropathol; 2007 Mar; 113(3):325-37. PubMed ID: 17265049
[TBL] [Abstract][Full Text] [Related]
4. Prognosis by tumor location in adults with spinal ependymomas.
Oh MC; Kim JM; Kaur G; Safaee M; Sun MZ; Singh A; Aranda D; Molinaro AM; Parsa AT
J Neurosurg Spine; 2013 Mar; 18(3):226-35. PubMed ID: 23311515
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.
Prayson RA
Ann Diagn Pathol; 1999 Feb; 3(1):11-8. PubMed ID: 9990108
[TBL] [Abstract][Full Text] [Related]
6. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
7. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
[TBL] [Abstract][Full Text] [Related]
8. The high incidence of tumor dissemination in myxopapillary ependymoma in pediatric patients. Report of five cases and review of the literature.
Fassett DR; Pingree J; Kestle JR
J Neurosurg; 2005 Jan; 102(1 Suppl):59-64. PubMed ID: 16206735
[TBL] [Abstract][Full Text] [Related]
9. Spinal myxopapillary ependymoma: neurological deterioration in patients treated with surgery.
Sakai Y; Matsuyama Y; Katayama Y; Imagama S; Ito Z; Wakao N; Kanemura T; Yoshida G; Sato K; Ando T; Nakamura H; Kato F; Yukawa Y; Ito K; Ishiguro N
Spine (Phila Pa 1976); 2009 Jul; 34(15):1619-24. PubMed ID: 19564773
[TBL] [Abstract][Full Text] [Related]
10. Prognosis by tumor location for pediatric spinal cord ependymomas.
Oh MC; Sayegh ET; Safaee M; Sun MZ; Kaur G; Kim JM; Aranda D; Molinaro AM; Gupta N; Parsa AT
J Neurosurg Pediatr; 2013 Mar; 11(3):282-8. PubMed ID: 23259510
[TBL] [Abstract][Full Text] [Related]
11. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
Suri VS; Tatke M; Singh D; Sharma A
Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
Terterov S; Krieger MD; Bowen I; McComb JG
J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
[TBL] [Abstract][Full Text] [Related]
13. Metastases of spinal myxopapillary ependymoma: unique characteristics and clinical management.
Kraetzig T; McLaughlin L; Bilsky MH; Laufer I
J Neurosurg Spine; 2018 Feb; 28(2):201-208. PubMed ID: 29219779
[TBL] [Abstract][Full Text] [Related]
14. Resection of myxopapillary ependymomas in children.
Bagley CA; Kothbauer KF; Wilson S; Bookland MJ; Epstein FJ; Jallo GI
J Neurosurg; 2007 Apr; 106(4 Suppl):261-7. PubMed ID: 17465358
[TBL] [Abstract][Full Text] [Related]
15. Myxopapillary ependymoma in children: a study of 11 cases and a comparison with the adult experience.
Cimino PJ; Agarwal A; Dehner LP
Pediatr Blood Cancer; 2014 Nov; 61(11):1969-71. PubMed ID: 25066546
[TBL] [Abstract][Full Text] [Related]
16. Surgical strategies and outcomes of spinal ependymomas of different lengths: analysis of 210 patients: clinical article.
Li TY; Chu JS; Xu YL; Yang J; Wang J; Huang YH; Kwan AL; Wang GH
J Neurosurg Spine; 2014 Aug; 21(2):249-59. PubMed ID: 24836662
[TBL] [Abstract][Full Text] [Related]
17. Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients.
Tarapore PE; Modera P; Naujokas A; Oh MC; Amin B; Tihan T; Parsa AT; Ames CP; Chou D; Mummaneni PV; Weinstein PR
Neurosurgery; 2013 Aug; 73(2):247-55; discussion 255. PubMed ID: 23670032
[TBL] [Abstract][Full Text] [Related]
18. Remarkable efficacy of temozolomide for relapsed spinal myxopapillary ependymoma with multiple recurrence and cerebrospinal dissemination: a case report and literature review.
Fujiwara Y; Manabe H; Izumi B; Shima T; Adachi N
Eur Spine J; 2018 Jul; 27(Suppl 3):421-425. PubMed ID: 29270703
[TBL] [Abstract][Full Text] [Related]
19. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.
Prayson RA
Am J Clin Pathol; 1998 Nov; 110(5):629-34. PubMed ID: 9802348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]